Fatma Eser
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- Antifungal resistance and susceptibility
- SARS-CoV-2 and COVID-19 Research
- Parasitic Diseases Research and Treatment
Papers in
-
- COVID-19 Clinical Research Studies 9
- SARS-CoV-2 detection and testing 3
- SARS-CoV-2 and COVID-19 Research 2
-
- Hepatitis B Virus Studies 2
- Co-authors
- Rahmet Güner (39 shared papers)Ayşe Kaya Kalem (29 shared papers)İmran Hasanoğlu (27 shared papers)Bircan Kayaaslan (23 shared papers)Gülay Korukluoğlu (3 shared papers)Esragül Akıncı (6 shared papers)Bircan Kayaaslan (5 shared papers)Müge Ayhan (8 shared papers)
- Journals
- Mycoses (3 papers)BMJ Open (2 papers)International Journal of Clinical Practice (2 papers)Vector-Borne and Zoonotic Diseases (1 paper)Epidemiology and Infection (1 paper)
- Partner nations
- TürkiyeUnited KingdomCambodia
In The Last Decade
Fatma Eser
39 papers receiving 630 citations
Peers
Comparison fields: 5 of 84
- Applied Microbiology and Biotechnology 41
- Infectious Diseases 295
- Obstetrics and Gynecology 81
- Neurology 129
- Critical Care and Intensive Care Medicine 29
Countries citing papers authored by Fatma Eser
This map shows the geographic impact of Fatma Eser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatma Eser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatma Eser more than expected).
Fields of papers citing papers by Fatma Eser
This network shows the impact of papers produced by Fatma Eser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatma Eser. The network helps show where Fatma Eser may publish in the future.
Co-authors
The 25 scholars most cited alongside Fatma Eser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 89 | |
| 2 | 2021 | 86 | |
| 3 | 2020 | 82 | |
| 4 | 2020 | 74 | |
| 5 | 2021 | 63 | |
| 6 | 2019 | 36 | |
| 7 | 2020 | 29 | |
| 8 | 2021 | 24 | |
| 9 | 2013 | 22 | |
| 10 | 2018 | 19 | |
| 11 | 2022 | 19 | |
| 12 | 2021 | 11 | |
| 13 | 2022 | 9 | |
| 14 | 2022 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2022 | 7 | |
| 17 | 2013 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2024 | 5 | |
| 20 | 2021 | 4 |
About Fatma Eser
Fatma Eser is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Neurology and Applied Microbiology and Biotechnology, having authored 45 papers that have together received 647 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (9 papers), Antibiotic Resistance in Bacteria (5 papers), Antibiotic Use and Resistance (3 papers), SARS-CoV-2 detection and testing (3 papers), Long-Term Effects of COVID-19 (3 papers), Hepatitis B Virus Studies (2 papers), COVID-19 Impact on Reproduction (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (41 citations), Infectious Diseases (295 citations), Obstetrics and Gynecology (81 citations), Neurology (129 citations) and Critical Care and Intensive Care Medicine (29 citations). Fatma Eser has collaborated with scholars based in Türkiye, United Kingdom and Cambodia. Frequent co-authors include Rahmet Güner, Ayşe Kaya Kalem, İmran Hasanoğlu, Bircan Kayaaslan, Gülay Korukluoğlu, Esragül Akıncı, Bircan Kayaaslan, Müge Ayhan, Deniz Erdem and Gamze Çapa Kaya. Their work appears in journals such as Mycoses, BMJ Open, International Journal of Clinical Practice, Vector-Borne and Zoonotic Diseases and Epidemiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.